Natasha M. DeVore, Ph.D. - Publications
Affiliations: | 2011 | Molecular Biosciences | University of Kansas, Lawrence, KS, United States |
Area:
BiochemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Petrunak EM, DeVore NM, Porubsky PR, Scott EE. Structures of human steroidogenic cytochrome P450 17A1 with substrates. The Journal of Biological Chemistry. 289: 32952-64. PMID 25301938 DOI: 10.1074/Jbc.M114.610998 | 0.599 | |||
2012 | DeVore NM, Scott EE. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes. The Journal of Biological Chemistry. 287: 26576-85. PMID 22700965 DOI: 10.1074/Jbc.M112.372813 | 0.742 | |||
2012 | DeVore NM, Scott EE. Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001. Nature. 482: 116-9. PMID 22266943 DOI: 10.1038/Nature10743 | 0.707 | |||
2012 | DeVore NM, Meneely KM, Bart AG, Stephens ES, Battaile KP, Scott EE. Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine. The Febs Journal. 279: 1621-31. PMID 22051186 DOI: 10.1111/J.1742-4658.2011.08412.X | 0.476 | |||
2009 | DeVore NM, Smith BD, Wang JL, Lushington GH, Scott EE. Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1319-27. PMID 19251817 DOI: 10.1124/Dmd.109.026765 | 0.72 | |||
2008 | DeVore NM, Smith BD, Urban MJ, Scott EE. Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 2582-90. PMID 18779312 DOI: 10.1124/Dmd.108.023770 | 0.761 | |||
Show low-probability matches. |